Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2662-8651
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment ; volume:3 ; number:1 ; day:17 ; month:8 ; year:2022 ; pages:1-20 ; date:12.2022
Molecular biomedicine ; 3, Heft 1 (17.8.2022), 1-20, 12.2022
- Creator
-
Hao, Yang
Chung, Chih Kit
Gu, Zili
Schomann, Timo
Dong, Xiaoxu
Veld, Ruben V. Huis in ‘t
Camps, Marcel G. M.
ten Dijke, Peter
Ossendorp, Ferry A.
Cruz, Luis J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-022-00086-z
- URN
-
urn:nbn:de:101:1-2022101920052784591116
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hao, Yang
- Chung, Chih Kit
- Gu, Zili
- Schomann, Timo
- Dong, Xiaoxu
- Veld, Ruben V. Huis in ‘t
- Camps, Marcel G. M.
- ten Dijke, Peter
- Ossendorp, Ferry A.
- Cruz, Luis J.
- SpringerLink (Online service)
Other Objects (12)
Photodynamic therapy changes tumour immunogenicity and promotes immune-checkpoint blockade response, particularly when combined with micromechanical priming
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Clinical development of photodynamic agents and therapeutic applications
Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma
Entinostat as a combinatorial therapeutic for rhabdomyosarcoma
Activation of phagocytosis by immune checkpoint blockade
Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy
Near‐Infrared‐II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis
Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade
Photodynamic therapy changes tumour immunogenicity and promotes immune-checkpoint blockade response, particularly when combined with micromechanical priming
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Clinical development of photodynamic agents and therapeutic applications
Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma
Entinostat as a combinatorial therapeutic for rhabdomyosarcoma
Activation of phagocytosis by immune checkpoint blockade
Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy
Near‐Infrared‐II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis
Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade
Photodynamic therapy changes tumour immunogenicity and promotes immune-checkpoint blockade response, particularly when combined with micromechanical priming
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Clinical development of photodynamic agents and therapeutic applications
Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma
Entinostat as a combinatorial therapeutic for rhabdomyosarcoma
Activation of phagocytosis by immune checkpoint blockade
Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy
Near‐Infrared‐II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis
Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade